Delivery Order SPE2DB22D1017-SPE2DB25FG8LV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 Unit Vials, valued at $5,128.74 under a firm fixed price contract structure. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BOTOX 200 unit vials. The $13,971.12 firm-fixed-price contract has a completion date of September 12, 2024 and was awarded on August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical that enables DLA to efficiently procure a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,667,812 units of BOTOX 200 unit vials. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a $21,534 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, with a completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of BOTOX. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency awarded a $12,821.85 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed price contract, with an ultimate completion date of August 14, 2025, represents a direct procurement of the pharmaceutical product without set-aside designation. The award was issued on July 24, 2025, with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,821.30 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,594,222 units of BOTOX 200 unit vials. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8LVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for BOTOX 100 Unit Vials, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's medical supply chain operations, which procures pharmaceuticals and medical supplies for military and veteran healthcare systems. AmerisourceBergen holds a significant $999.99 billion IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026, serving as a comprehensive global pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/30/25 |